Endometrial cancer

被引:59
作者
Arora, Vivek [1 ]
Quinn, Michael A. [1 ,2 ]
机构
[1] Royal Womens Hosp, Parkville, Vic 3052, Australia
[2] Univ Melbourne, Melbourne, Vic, Australia
关键词
endometrial cancer; fertility sparing treatment; conservative management; FERTILITY-SPARING TREATMENT; LYMPH-NODE METASTASIS; WELL-DIFFERENTIATED CARCINOMA; UTERINE CORPUS CANCER; D-AND-C; YOUNG-WOMEN; CONSERVATIVE-TREATMENT; ATYPICAL HYPERPLASIA; PREMENOPAUSAL WOMEN; MYOMETRIAL INVASION;
D O I
10.1016/j.bpobgyn.2011.12.007
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Endometrial carcinoma is the most common gynaecological malignancy in the Western world. The standard management of endometrial carcinoma is total hysterectomy and bilateral salpingo-oophorectomy with or without pelvic and para-aortic lymph-node dissection. Increasingly, endometrial cancer is being diagnosed in younger women in whom preserving fertility may be an important consideration when deciding optimal management. Conservative management of endometrial carcinoma may be a therapeutic option ill carefully selected women with well-differentiated endometrial cancer in the absence of any myometrial invasion or adnexal disease seen on imaging. The biggest concern with conservative management of endometrial carcinoma is disease progression while on treatment or after initial response to medical treatment. Women opting for conservative management should be aware that hormonal therapy is not the standard form of management. Potential adverse outcomes should be taken into consideration. Crown Copyright (C) 2012 Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:311 / 324
页数:14
相关论文
共 58 条
  • [21] Comparison of D&C and office endometrial biopsy accuracy in patients with FIGO grade 1 endometrial adenocarcinoma
    Leitao, Mario M., Jr.
    Kehoe, Siobhan
    Barakat, Richard R.
    Alektiar, Kaled
    Gattoc, Leda P.
    Rabbitt, Catherine
    Chi, Dennis S.
    Soslow, Robert A.
    Abu-Rustum, Nadeern R.
    [J]. GYNECOLOGIC ONCOLOGY, 2009, 113 (01) : 105 - 108
  • [22] Implementation of assisted reproductive technologies following conservative management of FIGO grade I endometrial adenocarcinoma and/or complex hyperplasia with atypia
    Lowe, MP
    Cooper, BC
    Sood, AK
    Davis, WA
    Syrop, CH
    Sorosky, JI
    [J]. GYNECOLOGIC ONCOLOGY, 2003, 91 (03) : 569 - 572
  • [23] Conservative surgical management of stage IA endometrial carcinoma for fertility preservation
    Mazzon, Ivan
    Corrado, Giacomo
    Masciullo, Valeria
    Morricone, Daniela
    Ferrandina, Gabriella
    Scambia, Giovanni
    [J]. FERTILITY AND STERILITY, 2010, 93 (04) : 1286 - 1289
  • [24] Progestin intrauterine device and GnRH analogue for uterus-sparing treatment of endometrial precancers and well-differentiated early endometrial carcinoma in young women
    Minig, L.
    Franchi, D.
    Boveri, S.
    Casadio, C.
    Bocciolone, L.
    Sideri, M.
    [J]. ANNALS OF ONCOLOGY, 2011, 22 (03) : 643 - 649
  • [25] Intrauterine progesterone treatment of early endometrial cancer
    Montz, FJ
    Bristow, RE
    Bovicelli, A
    Tomacruz, R
    Kurman, RJ
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2002, 186 (04) : 651 - 657
  • [26] Young patients with endometrial cancer: How many could be eligible for fertility-sparing treatment?
    Navarria, Isabelle
    Usel, Massimo
    Rapiti, Elisabetta
    Neyroud-Caspar, Isabelle
    Pelte, Marie-Francoise
    Bouchardy, Christine
    Petignat, Patrick
    [J]. GYNECOLOGIC ONCOLOGY, 2009, 114 (03) : 448 - 451
  • [27] Treatment results of endometrial hyperplasia after prospective D-score classification -: A follow-up study comparing effect of LNG-IUD and oral progestins versus observation only
    Orbo, Anne
    Arnes, Marit
    Hancke, Christine
    Vereide, Anne Beate
    Pettersen, Inger
    Larsen, Kurt
    [J]. GYNECOLOGIC ONCOLOGY, 2008, 111 (01) : 68 - 73
  • [28] ENDOMETRIAL CARCINOMA IN PREMENOPAUSAL WOMEN - A CLINICOPATHOLOGICAL STUDY
    QUINN, MA
    KNEALE, BJ
    FORTUNE, DW
    [J]. GYNECOLOGIC ONCOLOGY, 1985, 20 (03) : 298 - 306
  • [29] Hormonal therapy for the management of grade 1 endometrial adenocarcinoma: a literature review
    Ramirez, PT
    Frumovitz, M
    Bodurka, DC
    Sun, CC
    Levenback, C
    [J]. GYNECOLOGIC ONCOLOGY, 2004, 95 (01) : 133 - 138
  • [30] Progestin treatment of atypical hyperplasia and well-differentiated carcinoma of the endometrium in women under age 40
    Randall, TC
    Kurman, RJ
    [J]. OBSTETRICS AND GYNECOLOGY, 1997, 90 (03) : 434 - 440